Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients

The efficacy of current hepatitis C therapy in HIV/HCV‐coinfected patients is largely dependent on HCV genotype. The annual prevalence of HCV genotypes/subtypes and their influence on HCV clearance with antiviral treatment were examined in a dynamic cohort of HIV/HCV‐coinfected patients followed up...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of viral hepatitis 2011-05, Vol.18 (5), p.325-330
Hauptverfasser:	Medrano, J., Resino, S., Vispo, E., Madejón, A., Labarga, P., Tuma, P., Martín-Carbonero, L., Barreiro, P., Rodriguez-Novoa, S., Jiménez-Nacher, I., Soriano, V.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiviral Agents - administration & dosage Antiviral Agents - therapeutic use Cohort Studies Drug Therapy, Combination - trends Follow-Up Studies Genotype HCV genotypes Hepacivirus - classification Hepacivirus - drug effects Hepacivirus - genetics hepatitis C Hepatitis C - complications Hepatitis C - drug therapy Hepatitis C - epidemiology Hepatitis C - virology HIV HIV Infections - complications HIV Infections - epidemiology HIV Seropositivity Humans Incidence Interferons - therapeutic use Male pegylated interferon Population Dynamics Prevalence Ribavirin - therapeutic use RNA, Viral - blood RNA, Viral - genetics Substance Abuse, Intravenous treatment uptake
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!